| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |